Katrina J. Church - Dec 20, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Dec 20, 2024
Transactions value $
$0
Form type
4
Date filed
12/23/2024, 05:28 PM
Previous filing
Jun 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise $0 +8.6K +20.87% $0.00 49.8K Dec 20, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -8.6K -100% $0.00 0 Dec 20, 2024 Class A Common Stock 8.6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs vested 50% on the twelve-month anniversary of the date of grant, and the remaining 50% vested on the eighteenth-month anniversary of the date of grant, subject to the Reporting Person continuing in service through the applicable vesting date.